U.S., China at JCCT signal lack of progress on biotechnology approval process

U.S. Trade Representative Michael Froman and China's Vice Premier for State Council Wang Yang signaled that little progress has been made on expediting China's biotech approval system, in Nov. 22 remarks on the margins of the U.S.-China Joint Commission on Commerce and Trade meeting in Washington, DC. China's approval system for biotech products has long drawn the ire of the U.S. government and industry for being unpredictable and untimely. Last week, 37 senators sent a letter to President Obama requesting...